Lakeshore Biopharma Co. Ltd.
13F holders, Q3 2024 (September 30)7holders −4
1new positions
5sold out
$0.69avg. 13F price*
At the end of Q3 2024, 7 institutions reported holding Lakeshore Biopharma Co. Ltd. in their 13F filings, down 4 from Q2 2024. 1 opened new positions and 5 sold out. The largest holders were FMR LLC ($803K), HHLR Advisors, LTD. ($513K) and FIL Ltd ($424K).
- Company
- Lakeshore Biopharma Co. Ltd.
- CUSIP
- G9845F109
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $34K |
| Exits | 5 | $963K |
All 13F filers, Q2 2024 → Q3 2024: 49,418 shares bought and 1,937,078 shares sold, net −1,887,660 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| FMR LLC | 0.00% | No change | 1,165,071 | $803K |
| HHLR Advisors, LTD. | 0.01% | No change | 751,790 | $513K |
| FIL Ltd | 0.00% | Reduce -16.1% | 615,475 | $424K |
| Superstring Capital Management LP | 0.19% | No change | 307,920 | $212K |
| Barclays PLC | 0.00% | No change | 247,575 | $169K |
| Bank of Montreal | 0.00% | Reduce -68.0% | 93,808 | $76K |
| UBS Group AG | 0.00% | New | 49,418 | $34K |
"% of holder's portfolio" is LAKESHORE BIOPHARMA CO LTD's weight in each manager's 13F, not the share of Lakeshore Biopharma Co. Ltd. the manager owns.